Market News

ONGC Share Price Live Updates: ONGC maintains a steady beta over six months

Hero MotoCorp Share Price Live Updates: Hero MotoCorp's beta indicates potential investment risk

Wipro Share Price Live Updates: Wipro's low beta signals investor confidence

Axis Bank Share Price Live Updates: Axis Bank's six-month beta reflects market volatility

FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market

Wockhardt’s newly approved antibiotic Zaynich has the potential to transform the treatment of drug-resistant infections, according to Mahesh Patel, the scientist behind the drug. Approved by the US FDA for complicated urinary tract infections, Zaynich combines cefepime and zidebactam, using a novel “beta-lactam enhancer” mechanism that blocks two key steps in bacterial cell-wall synthesis, helping it overcome virtually all known resistance mechanisms.

Apollo Hospital Share Price Live Updates: Analyzing Apollo Hospital's beta

Beta Drugs consolidated net profit rises 0.22% in the March 2026 quarter

Sales rise 0.21% to Rs 93.96 crore

JSW Steel Share Price Live Updates: JSW Steel's 6-Month Beta Highlights Risk Profile

Wipro Share Price Live Updates: Wipro's beta indicates a defensive stock

ONGC Share Price Live Updates: ONGC's beta showcases its market positioning

Hindalco Share Price Live Updates: Hindalco's beta indicates a volatile trading environment

Divis Labs Share Price Live Updates: Divis Labs maintains a beta of 0.7686 in the last six months